The company remains focused on delivering sustainable growth and shareholder value while making appropriate investments for the future. Strategic objectives include improving operating effectiveness and balance sheet productivity, which are essential for driving an efficient capital structure and strong shareholder returns. Management reviews quarterly forecast data, monthly actual results, and segment sales to assess outcomes and financial performance. The company continues to invest in research and development, geographic expansion, and new product promotions to drive further revenue and profit growth, emphasizing the importance of operational efficiency and organizational effectiveness. The ability to expand core business and develop innovative new products is critical for sustaining long-term growth. The company evaluates its performance using foreign currency-neutral information to improve understanding of operating results. The medical segment's revenue growth was driven by sales in medication management solutions and procedural solutions, with international growth impacted by the divestiture of the respiratory solutions business. The life sciences segment's revenue growth reflected increased sales in preanalytical systems and diagnostics, particularly in emerging markets. The company faces challenges such as pricing pressure and the need for government funding in emerging markets, which could adversely impact business performance. The integration of acquired companies, such as CareFusion, has involved significant restructuring costs and transformation efforts, including impairments related to internal-use software assets. The company also faces risks associated with security breaches of information technology systems, which could compromise sensitive information and impact business operations. The ongoing transformation of the IT function is aimed at enhancing operational capabilities and supporting business strategies. The assessment of goodwill and intangible assets for impairment is conducted regularly, reflecting the company's commitment to maintaining effective management of its resources. The company’s financial position remains strong, with significant cash flows from operating activities, which are essential for funding future investments and acquisitions. The ability to manage market risks, including foreign currency exchange and interest rate risks, is critical for maintaining financial stability. The company’s strategic management practices are designed to optimize resource allocation and enhance organizational capabilities, ensuring alignment with business strategies and market demands. The focus on digital transformation and IT deployment is integral to achieving competitive advantage and operational flexibility. The company’s governance frameworks support effective decision-making and resource mobilization, allowing for responsiveness to market dynamics and external influences. Overall, the integration of technology capabilities into business processes is essential for driving innovation and improving firm performance.